Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


38 Special: How FDA Shot Down Drug Shortages In 2010

Executive Summary

By working with sponsors, FDA averted 38 drug shortages in 2010, the agency reports.

You may also be interested in...

FDA’s Drug Shortage Reg Adds More Manufacturers, Products To Notification List

Interim final rule redefines the terms “sole manufacturer” and “discontinuance.”

FDA’s Drug Shortage Prevention Tally: 96 Saves In Six Weeks

At Senate hearing, the agency says an executive order has helped spur notifications, while the GAO suggests Congress require manufacturers to tell FDA about anything that could affect the drug supply. Reimbursement changes will not solve the shortage problem, an HHS official argues.

FDA's Drug Shortages Strategy Focuses On Prevention, Not "Empire Building"

FDA would like additional funding for a number of its programs, but it does not appear that the agency will be pushing to expand its drug shortage team.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts